Nasdaq: Oramed Unit, Genomma Lab Join To Commercialize Oral COVID-19 Vaccine Candidate In Mexico

Oramed Pharmaceuticals Inc. (ORMP) and Genomma Lab Internacional announced the formation of a 50/50 joint venture between Genomma Lab and Oramed’s majority-owned subsidiary Oravax Medical to develop and commercialize Oravax’s COVID-19 vaccine candidate in Mexico. Oramed and Genomma Lab also announced their plans to enter into a $20 million share swap. Genomma Lab has also […]

H.C. Wainwright 6th Annual Israel Conference

CEO Nadav Kidron will present a company overview at the H.C. Wainwright6th Annual Israel Conference. Presentation Details:H.C. Wainwright 6th Annual Israel ConferencePresenter:  Nadav Kidron, CEODate: Thursday, November 12, 2020Time: 11:30 AM ET

Oramed Reaches 75% Enrollment in Phase 3 Oral Insulin Study

NEW YORK, Nov. 23, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (, a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has enrolled and randomized over 75% of the 675 patients planned for its Phase 3 ORA-D-013-1 study of its oral insulin capsule ORMD-0801 […]

Join our mailing list

Skip to content